Reshape Biotech Analysis: $8M Raised
What is Reshape Biotech?
Reshape Biotech automates lab experiments and data capture, providing AI-driven analysis to enhance scientific research and decision-making.
Employees
40
Founded
2018
Revenue
$3.8-8.3M
Company Stage
Seed
YC Batch
W21
Product Features & Capabilities
- Discovery Platform, Imaging Device, High-throughput Imaging Device, automated imaging and analysis, real-time AI analysis, machine learning insights, data standardization, scalable innovation.
How much Reshape Biotech raised
Seed - $8.1 million
Not specifiedLead Investor: Not specified
Company Pricing
- Start-up: $2,417 per month, paid annually
- 1 incubated Imaging Device
- Out-of-the-box AI models
- Single lab platform access
- Smooth onboarding to get you started
- Standard: $11,999 per month, paid annually
- 5 incubated Imaging Devices
- Out-of-the-box AI models
- Single
Investors
- Reshape Biotech raised $20 million in a Series A funding round.
- The investors involved in this funding round have not been explicitly named in the available sources.
See something that needs updating? Suggest edits to this profile.